ZAPTRA 12.5

1. SPECIFICATIONS

Product Name: Zaptra 12.5
Generic Name: Paroxetine Extended Release and Clonazepam Tablets
Product Type: Prescription Medicine (Schedule H, NRx)
Form: Film-coated tablet
Specifications & Ingredients
Each film-coated tablet contains:
Paroxetine Hydrochloride IP (equivalent to Paroxetine): 12.5 mg (as Extended Release)
Clonazepam IP: 0.5 mg
Colors: Ferric Oxide Yellow USP-NF & Titanium Dioxide IP
Excipients: Q.S. (Quantum Satis)
2. General Information
Classification: Schedule H Prescription Drug. The label carries a mandatory warning: “To be sold by retail on the prescription of a Psychiatrist only.”
Storage: Store at room temperature, protected from light and moisture. Keep out of reach of children.
Food Preference/FSSAI: Not applicable (this is a pharmaceutical product, not a food or dietary supplement).
3. Directions for Use
Administration: The tablet must be swallowed as a whole.
Warning: Do not chew or crush the tablet.
Dosage: As directed by the physician.
4. Manufacturer Information
Manufactured by: INTAS PHARMACEUTICALS LTD.
Manufacturing Location: Bagheykhola, Majhitar, Sikkim – 737136, INDIA.
Manufacturing License No.: M/517/09
5. Product Description
Purpose: Zaptra 12.5 is a combination medication typically used for the treatment of certain mood and anxiety disorders.
Paroxetine is a Selective Serotonin Reuptake Inhibitor (SSRI) commonly used for depression, panic disorder, and anxiety.
Clonazepam is a benzodiazepine used to help manage anxiety or panic symptoms.
Extended Release (ER): The “Extended Release” formulation is designed to release the medication gradually into your system over a prolonged period.
6. Important Safety Note: This medication contains a benzodiazepine (Clonazepam), which carries risks of dependency, withdrawal symptoms, and sedation. It is essential to follow your psychiatrist’s dosage instructions exactly and never stop taking this medication abruptly without medical supervision. Do not consume alcohol while taking this medication, as it may cause dangerous levels of sedation.